Clinical Epidemiology

II. The Identification Rates of Disease

  1. ALVAN R. FEINSTEIN, M.D., F.A.C.P.
  1. Requests for reprints should be addressed to Alvan R. Feinstein, M.D., Yale University School of Medicine,
    333 Cedar St., New Haven, Conn. 06510
    .

Excerpt

OUTLINE OF CONTENTS: PART II INTRODUCTION

FACTORS INFLUENCING IDENTIFICATION OF DISEASE

CHANGES IN NOMENCLATURE AND TECHNOLOGY

DISSEMINATION OF NEW STANDARDS

CHANGES IN IATROTROPY

CHANGES IN CODIFICATION

THE EPIDEMIOLOGIC SPECTRUM OF A DISEASE

IATROTROPIC AND DIAGNOSTIC PATHWAYS

CONSTRUCTION OF THE EPIDEMIOLOGIC SPECTRUM

CHANGES IN DIAGNOSTIC PROCEDURES

FASHIONS OF NOMENCLATURE

ECLECTIC DIAGNOSTIC CRITERIA

NEW TECHNOLOGIC TESTS

SUMMARY

INTRODUCTION When vital statistics was established more than a century ago as a numerical domain in what might now be called Clinical Epidemiology, the main problem was to arrange for collection of data (1, 2). Clinicians had to become accustomed to documenting births and deaths

Article and Author Information

  • From the Eastern Research Support Center and the Department of Medicine, West Haven Veterans Administration Hospital, West Haven; and the Departments of Medicine and Epidemiology, Yale University School of Medicine, New Haven; Conn

  • This study was supported in part by grant 13977-03-68-806, U. S. Public Health Service Cancer Control Program, Department of Health, Education and Welfare, Washington, D. C.

    • Received April 8, 1968.
    • Accepted May 31, 1968.
« Previous | Next Article »Table of Contents